Insider Trading activities at Ionis Pharmaceuticals Inc (IONS) , Part 3

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ionis Pharmaceuticals Inc (IONS) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ionis Pharmaceuticals Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 874015.

Total stock buying since 2015: $477,900.
Total stock sales since 2015: $209,463,995.
Total stock option exercises since 2015: $78,074,596.


27 insiders reported insider trading activities at Ionis Pharmaceuticals Inc (IONS):
Insider trading activities of Castleman Breaux
Insider trading activities of Devers Shannon L.
Insider trading activities of Reikes Peter N
Insider trading activities of Crooke Stanley T
Insider trading activities of Herman Joan E
Insider trading activities of O'neil Patrick R.
Insider trading activities of Loscalzo Joseph
Insider trading activities of Jenne Kyle
Insider trading activities of Hayden Michael R
Insider trading activities of Diaz Allene M.
Insider trading activities of Boyce Sarah
Insider trading activities of Schneider Eugene
Insider trading activities of Klein Joseph Iii
Insider trading activities of Birchler Brian
Insider trading activities of Monia Brett P
Insider trading activities of Yang Michael J.
Insider trading activities of Mcdevitt Damien
Insider trading activities of Bennett C Frank
Insider trading activities of Muto Frederick T
Insider trading activities of Cadoret-manier Onaiza
Insider trading activities of Parshall B Lynne
Insider trading activities of Wender Joseph H
Insider trading activities of Hougen Elizabeth L
Insider trading activities of Swayze Eric
Insider trading activities of Geary Richard S
Insider trading activities of Berthelsen Spencer R
Insider trading activities of Baroldi Joseph

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Ionis Pharmaceuticals Inc (IONS).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 15,000 $477,900 819,970 $43,380,174 939,780 $18,024,606
2024 0 $0 216,854 $10,417,483 306,713 $1,690,800
2023 0 $0 480,350 $22,469,267 633,770 $17,444,961
2022 0 $0 9,319 $373,594 272,987 $291,150
2021 0 $0 128,563 $7,483,627 277,627 $139,500
2020 0 $0 435,149 $22,468,509 430,271 $8,790,881
2019 0 $0 528,804 $37,414,368 631,186 $18,611,478
2018 0 $0 237,729 $11,778,492 331,168 $2,959,654
2017 0 $0 327,296 $17,001,714 394,558 $3,417,846
2016 0 $0 240,936 $9,522,537 302,772 $2,241,037
2015 0 $0 422,957 $27,154,230 458,215 $4,462,683


Table 3. Detailed insider trading at Ionis Pharmaceuticals Inc (IONS) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2020-12-02 Bennett C Frank (Chief Scientific Officer) Option Ex 7,053 39.87 281,203
2020-11-25 Geary Richard S (EVP, Development) Sale 11,920 50.05 596,596
2020-11-25 Geary Richard S (EVP, Development) Option Ex 11,920 39.87 475,250
2020-11-25 Hougen Elizabeth L (EVP, Finance & CFO) Sale 21,680 50.05 1,085,084
2020-11-25 Hougen Elizabeth L (EVP, Finance & CFO) Option Ex 21,680 39.87 864,381
2020-11-25 Parshall B Lynne Sale 3,590 50.05 179,679
2020-11-25 Parshall B Lynne Option Ex 3,590 39.87 143,133
2020-11-25 Crooke Stanley T (Exec Chairman of the Board) Sale 12,990 50.05 650,149
2020-11-25 Crooke Stanley T (Exec Chairman of the Board) Option Ex 12,990 39.87 517,911
2020-11-24 Geary Richard S (EVP, Development) Sale 2,380 50.83 120,975
2020-11-24 Geary Richard S (EVP, Development) Option Ex 2,380 39.87 94,890
2020-11-24 Hougen Elizabeth L (EVP, Finance & CFO) Sale 4,320 50.83 219,585
2020-11-24 Hougen Elizabeth L (EVP, Finance & CFO) Option Ex 4,320 39.87 172,238
2020-11-24 Parshall B Lynne Sale 710 50.82 36,082
2020-11-24 Parshall B Lynne Option Ex 710 39.87 28,307
2020-11-24 Crooke Stanley T (Exec Chairman of the Board) Sale 2,590 50.83 131,649
2020-11-24 Crooke Stanley T (Exec Chairman of the Board) Option Ex 2,590 39.87 103,263
2020-11-23 Geary Richard S (EVP, Development) Sale 10,700 50.11 536,177
2020-11-23 Geary Richard S (EVP, Development) Option Ex 10,700 39.87 426,609
2020-11-23 Hougen Elizabeth L (EVP, Finance & CFO) Sale 19,000 50.11 952,090
2020-11-23 Hougen Elizabeth L (EVP, Finance & CFO) Option Ex 19,000 39.87 757,530
2020-11-23 Parshall B Lynne Sale 3,200 50.12 160,384
2020-11-23 Parshall B Lynne Option Ex 3,200 39.87 127,583
2020-11-23 Crooke Stanley T (Exec Chairman of the Board) Sale 12,100 50.05 605,665
2020-11-23 Crooke Stanley T (Exec Chairman of the Board) Option Ex 12,100 39.87 482,426
2020-11-03 Bennett C Frank (Chief Scientific Officer) Sale 15,000 46.77 701,595
2020-11-03 Bennett C Frank (Chief Scientific Officer) Option Ex 15,000 39.87 598,050
2020-10-20 Klein Joseph Iii Sale 2,889 46.86 135,387
2020-10-15 Reikes Peter N Option Ex 1,778 .00 0
2020-10-15 Hayden Michael R Option Ex 1,778 .00 0
2020-09-22 Crooke Stanley T (Exec Chairman of the Board) Sale 50,000 50.41 2,520,450
2020-09-21 Crooke Stanley T (Exec Chairman of the Board) Sale 2,000 50.18 100,360
2020-09-16 Wender Joseph H Option Ex 22,500 20.70 465,862
2020-09-01 Monia Brett P (Chief Executive Officer) Sale 314 53.70 16,861
2020-07-06 Castleman Breaux Option Ex 667 .00 0
2020-07-06 Loscalzo Joseph Option Ex 667 .00 0
2020-07-06 Klein Joseph Iii Option Ex 667 .00 0
2020-07-06 Muto Frederick T Option Ex 667 .00 0
2020-07-06 Berthelsen Spencer R Option Ex 667 .00 0
2020-07-06 Wender Joseph H Option Ex 667 .00 0
2020-07-02 Castleman Breaux Option Ex 889 .00 0
2020-07-02 Loscalzo Joseph Option Ex 889 .00 0
2020-07-02 Klein Joseph Iii Option Ex 889 .00 0
2020-07-02 Muto Frederick T Option Ex 889 .00 0
2020-07-02 Berthelsen Spencer R Option Ex 889 .00 0
2020-07-02 Parshall B Lynne Option Ex 889 .00 0
2020-07-02 Wender Joseph H Option Ex 889 .00 0
2020-07-01 Reikes Peter N Option Ex 1,778 .00 0
2020-07-01 Hayden Michael R Option Ex 1,778 .00 0
2020-07-01 Castleman Breaux Option Ex 2,444 .00 0
2020-07-01 Loscalzo Joseph Option Ex 2,444 .00 0
2020-07-01 Herman Joan E Option Ex 1,778 .00 0
2020-07-01 Klein Joseph Iii Option Ex 2,444 .00 0
2020-07-01 Muto Frederick T Option Ex 2,444 .00 0
2020-07-01 Berthelsen Spencer R Option Ex 2,444 .00 0
2020-07-01 Parshall B Lynne Option Ex 1,778 .00 0
2020-07-01 Wender Joseph H Option Ex 2,444 .00 0
2020-06-30 Muto Frederick T Option Ex 15,000 9.22 138,300
2020-06-25 Castleman Breaux (Director) Sale 10,000 60.00 600,000
2020-06-25 Castleman Breaux (Director) Option Ex 10,000 26.66 266,600
2020-06-25 Bennett C Frank (EVP, Chief Scientific Officer) Sale 15,000 59.77 896,505
2020-06-25 Bennett C Frank (EVP, Chief Scientific Officer) Option Ex 15,000 39.87 598,050
2020-06-25 Crooke Stanley T (Exec Chairman of the Board) Sale 9,914 60.11 595,910
2020-06-24 Crooke Stanley T (Exec Chairman of the Board) Sale 5,000 58.80 294,000
2020-06-23 Berthelsen Spencer R (Director) Sale 15,000 58.76 881,400
2020-06-23 Berthelsen Spencer R (Director) Option Ex 15,000 9.22 138,300
2020-06-19 Crooke Stanley T (Exec Chairman of the Board) Sale 10,000 58.33 583,250
2020-06-17 Crooke Stanley T (Exec Chairman of the Board) Sale 17,000 58.08 987,292
2020-06-10 Herman Joan E (Director) Option Ex 3,556 .00 0
2020-03-25 Crooke Stanley T (Exec Chairman of the Board) Sale 16,000 47.00 752,000
2020-03-19 Crooke Stanley T (Exec Chairman of the Board) Sale 16,000 45.25 724,032
2020-03-17 Crooke Stanley T (Exec Chairman of the Board) Sale 20,390 44.75 912,452
2020-02-10 O'neil Patrick R. (SVP & General Counsel) Sale 3,882 59.60 231,367
2020-01-15 Swayze Eric (SVP, Research) Option Ex 6,522 .00 0
2020-01-15 O'neil Patrick R. (SVP, Legal & General Counsel) Option Ex 12,045 .00 0
2020-01-15 Monia Brett P (Chief Executive Officer) Option Ex 19,921 .00 0
2020-01-15 Geary Richard S (SVP, Development) Option Ex 13,139 .00 0
2020-01-15 Hougen Elizabeth L (SVP, Finance & CFO) Option Ex 12,044 .00 0
2020-01-15 Bennett C Frank (Chief Scientific Officer) Option Ex 11,711 .00 0
2020-01-15 Parshall B Lynne (Director) Option Ex 15,136 .00 0
2020-01-15 Crooke Stanley T (Executive Chairman of Board) Option Ex 42,960 .00 0
2020-01-02 Monia Brett P (Chief Executive Officer) Sale 173 60.25 10,423
2019-12-23 Klein Joseph Iii (Director) Sale 1,000 61.87 61,874
2019-12-23 Klein Joseph Iii (Director) Option Ex 1,000 35.53 35,530
2019-12-20 Hougen Elizabeth L (SVP, Finance & CFO) Option Ex 10,634 10.82 115,059
2019-12-16 Klein Joseph Iii (Director) Sale 1,000 65.45 65,447
2019-12-16 Klein Joseph Iii (Director) Option Ex 1,000 35.53 35,530
2019-12-09 Klein Joseph Iii (Director) Sale 1,000 63.74 63,745
2019-12-09 Klein Joseph Iii (Director) Option Ex 1,000 35.53 35,530
2019-12-04 Geary Richard S (SVP, Development) Sale 10,000 65.00 650,000
2019-12-04 Geary Richard S (SVP, Development) Option Ex 10,000 14.69 146,900
2019-12-04 Hougen Elizabeth L (SVP, Finance & CFO) Sale 4,566 65.00 296,790
2019-12-04 Hougen Elizabeth L (SVP, Finance & CFO) Option Ex 4,566 10.82 49,404
2019-12-02 Geary Richard S (SVP, Development) Sale 5,000 65.06 325,285
2019-12-02 Geary Richard S (SVP, Development) Option Ex 5,000 14.69 73,450
2019-12-02 Klein Joseph Iii (Director) Sale 1,000 64.08 64,083
2019-12-02 Klein Joseph Iii (Director) Option Ex 1,000 35.53 35,530
2019-11-25 Klein Joseph Iii (Director) Sale 812 62.90 51,074
2019-11-25 Hougen Elizabeth L (SVP, Finance & CFO) Sale 4,000 62.50 250,000
2019-11-25 Hougen Elizabeth L (SVP, Finance & CFO) Option Ex 4,000 10.82 43,280
2019-11-20 Monia Brett P (COO & SVP, Translational Med) Sale 5,776 60.01 346,617
2019-11-20 Klein Joseph Iii (Director) Sale 2,000 60.00 120,000
2019-11-19 Hougen Elizabeth L (SVP, Finance & CFO) Sale 4,000 58.80 235,200
2019-11-19 Hougen Elizabeth L (SVP, Finance & CFO) Option Ex 4,000 10.82 43,280
2019-10-15 Reikes Peter N (Director) Option Ex 1,778 .00 0
2019-10-15 Hayden Michael R (Director) Option Ex 1,778 .00 0
2019-08-21 Crooke Stanley T (Chairman and CEO) Sale 10,000 72.15 721,500
2019-08-21 Crooke Stanley T (Chairman and CEO) Option Ex 10,000 39.87 398,700
2019-08-20 Crooke Stanley T (Chairman and CEO) Sale 12,000 71.00 852,000
2019-08-20 Crooke Stanley T (Chairman and CEO) Option Ex 12,000 39.87 478,439
2019-07-18 Crooke Stanley T (Chairman & CEO) Sale 10,000 70.25 702,510
2019-07-18 Crooke Stanley T (Chairman & CEO) Option Ex 10,000 39.87 398,700
2019-07-15 Mcdevitt Damien (Chief Business Officer) Option Ex 3,542 .00 0
2019-07-03 Loscalzo Joseph (Director) Option Ex 667 .00 0
2019-07-03 Klein Joseph Iii (Director) Option Ex 667 .00 0
2019-07-03 Muto Frederick T (Director) Option Ex 667 .00 0
2019-07-03 Wender Joseph H (Director) Option Ex 667 .00 0
2019-07-02 Monia Brett P (Chief Operating Officer) Sale 210 66.40 13,944
2019-07-02 Loscalzo Joseph (Director) Option Ex 889 .00 0
2019-07-02 Klein Joseph Iii (Director) Option Ex 889 .00 0
2019-07-02 Muto Frederick T (Director) Option Ex 889 .00 0
2019-07-02 Parshall B Lynne (Director) Option Ex 889 .00 0
2019-07-02 Wender Joseph H (Director) Option Ex 889 .00 0
2019-07-01 Loscalzo Joseph (Director) Option Ex 1,333 .00 0
2019-07-01 Klein Joseph Iii (Director) Option Ex 1,333 .00 0
2019-07-01 Muto Frederick T (Director) Option Ex 1,333 .00 0
2019-07-01 Wender Joseph H (Director) Option Ex 1,333 .00 0
2019-06-24 Berthelsen Spencer R (Director) Sale 15,000 63.60 954,075
2019-06-24 Berthelsen Spencer R (Director) Option Ex 15,000 16.32 244,800
2019-06-04 Muto Frederick T (Director) Sale 15,000 65.29 979,350
2019-06-04 Muto Frederick T (Director) Option Ex 15,000 16.32 244,800
2019-05-06 Muto Frederick T (Director) Sale 8,000 72.75 582,000
2019-05-06 Muto Frederick T (Director) Option Ex 8,000 24.42 195,360
2019-04-29 Parshall B Lynne (Director) Sale 50,000 75.01 3,750,650
2019-04-29 Parshall B Lynne (Director) Option Ex 50,000 39.87 1,993,499
2019-04-16 Crooke Stanley T (Chairman and CEO) Sale 21,000 84.70 1,778,763
2019-04-16 Crooke Stanley T (Chairman and CEO) Option Ex 21,000 26.31 552,573
2019-04-15 Crooke Stanley T (Chairman and CEO) Sale 11,000 85.25 937,750
2019-04-15 Crooke Stanley T (Chairman and CEO) Option Ex 11,000 12.76 140,305
2019-04-08 Geary Richard S (SVP, Development) Sale 46,240 84.01 3,884,529
2019-04-08 Geary Richard S (SVP, Development) Option Ex 46,240 33.97 1,570,634
2019-04-05 O'neil Patrick R. (SVP Legal & General Counsel) Sale 2,252 84.75 190,857
2019-04-05 O'neil Patrick R. (SVP Legal & General Counsel) Option Ex 2,252 61.68 138,903
2019-04-04 O'neil Patrick R. (SVP Legal & General Counsel) Sale 39,622 83.23 3,297,659
2019-04-04 O'neil Patrick R. (SVP Legal & General Counsel) Option Ex 36,622 54.81 2,007,251
2019-04-03 O'neil Patrick R. (SVP Legal & General Counsel) Sale 7,654 84.83 649,288
2019-04-03 O'neil Patrick R. (SVP Legal & General Counsel) Option Ex 7,654 61.68 472,098
2019-03-19 Wender Joseph H (Director) Sale 10,000 79.63 796,260
2019-03-18 O'neil Patrick R. (SVP Legal & General Counsel) Sale 28,800 78.79 2,269,180
2019-03-18 O'neil Patrick R. (SVP Legal & General Counsel) Option Ex 28,800 61.57 1,773,216

Insider trading activities including stock purchases, stock sales, and option exercises of IONS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ionis Pharmaceuticals Inc (symbol IONS, CIK number 874015) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.